Screener
MetLife MET Gain (Loss) on Derivative Instruments, Net, Pretax
Gain (Loss) on Derivative Instruments, Net, Pretax at other companies
Other financials
Where this comes from
Reported directly by MetLife in its filing.
Tagged under the XBRL concept us-gaap:GainLossOnDerivativeInstrumentsNetPretax.
The source filing: MetLife’s 10-Q, filed May 7, 2026. Open the filing →
- Filed
- May 7, 2026, 5:09 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001099219-26-000035
FAQ
- What is MetLife's gain (loss) on derivative instruments, net, pretax?
- MetLife (MET) reported gain (loss) on derivative instruments, net, pretax of $74M in Q1 2026.
- How has MetLife's gain (loss) on derivative instruments, net, pretax changed year-over-year?
- MetLife's gain (loss) on derivative instruments, net, pretax decreased by 82.9% year-over-year, from $432M to $74M.
- What is the long-term trend for MetLife's gain (loss) on derivative instruments, net, pretax?
- Over 4 years (2021 to 2025), MetLife's gain (loss) on derivative instruments, net, pretax has grown at a -12.2% compound annual growth rate (CAGR), from -$3.26B to -$1.94B.
- What does gain (loss) on derivative instruments, net, pretax mean?
- This represents the net change in fair value and realized gains or losses from derivative financial instruments used for hedging or risk management. It is a key indicator of the effectiveness of the company's hedging strategies against market risks.
Ask your AI about MetLife's gain (loss) on derivative instruments, net, pretax.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude